Table 2.
Crude | Model 1 | Model 2 | ||||
---|---|---|---|---|---|---|
β (95% CI) | p | β (95% CI) | p | β (95% CI) | p | |
CDR 0.5 | −0.89 (−2.53; 0.75) | 0.286 | −0.41 (−2.01; 1.20) | 0.620 | −0.84 (−2.39; 0.71) | 0.288 |
CDR 1 | −0.65 (−2.54; 1.25) | 0.502 | 0.40 (−1.48; 2.27) | 0.678 | 0.04 (−1.76; 1.84) | 0.965 |
CDR 2 | −2.77 (−4.73; −0.81) | 0.005 | −2.02 (−3.96; −0.09) | 0.039 | −1.92 (−3.77; −0.06) | 0.042 |
CDR 3 | −4.47 (−5.49; −3.45) | <0.001 | −3.47 (−4.52; −2.42) | <0.001 | −2.91 (−3.97; −1.86) | <0.001 |
Reference: CDR 0 (without dementia).
CDR 0.5 (questionable dementia), CDR 1 (mild dementia), CDR 2 (moderate dementia), and CDR 3 (severe dementia).
Model 1: linear regression model, adjusted for age, sex, race, and education.
Model 2: linear regression model, adjusted for age, sex, race, education, hypertension, diabetes, coronary artery disease, heart failure, dyslipidemia, cancer, physical inactivity, alcohol use, and smoking.